{"organizations": [], "uuid": "d75a2b9b6b120cbefbf0d4d96e4151c2a13b1513", "thread": {"social": {"gplus": {"shares": 0}, "pinterest": {"shares": 0}, "vk": {"shares": 0}, "linkedin": {"shares": 0}, "facebook": {"likes": 0, "shares": 0, "comments": 0}, "stumbledupon": {"shares": 0}}, "site_full": "www.reuters.com", "main_image": "https://s4.reutersmedia.net/resources_v2/images/rcom-default.png", "site_section": "http://www.reuters.com/resources/archive/us/20180305.html", "section_title": "Archive News &amp; Video for Monday, 05 Mar 2018 | Reuters.com", "url": "https://www.reuters.com/article/brief-arcus-biosciences-now-sees-ipo-of/brief-arcus-biosciences-now-sees-ipo-of-up-to-7-1-mln-shares-priced-between-13-and-15-per-share-idUSFWN1QN0E4", "country": "US", "domain_rank": 408, "title": "BRIEF-Arcus Biosciences ‍​Now Sees IPO Of Up To 7.1 Mln Shares Priced Between $13 And $15 Per Share", "performance_score": 0, "site": "reuters.com", "participants_count": 1, "title_full": "", "spam_score": 0.074, "site_type": "news", "published": "2018-03-05T19:46:00.000+02:00", "replies_count": 0, "uuid": "d75a2b9b6b120cbefbf0d4d96e4151c2a13b1513"}, "author": "Reuters Editorial", "url": "https://www.reuters.com/article/brief-arcus-biosciences-now-sees-ipo-of/brief-arcus-biosciences-now-sees-ipo-of-up-to-7-1-mln-shares-priced-between-13-and-15-per-share-idUSFWN1QN0E4", "ord_in_thread": 0, "title": "BRIEF-Arcus Biosciences ‍​Now Sees IPO Of Up To 7.1 Mln Shares Priced Between $13 And $15 Per Share", "locations": [], "entities": {"persons": [], "locations": [], "organizations": [{"name": "reuters", "sentiment": "negative"}, {"name": "arcus biosciences inc", "sentiment": "negative"}, {"name": "sec", "sentiment": "none"}]}, "highlightText": "", "language": "english", "persons": [], "text": "March 5 (Reuters) -\n* ARCUS BIOSCIENCES INC ‍​NOW SEES IPO OF UP TO 7.1 MILLION SHARES OF COMMON STOCK PRICED BETWEEN $13.00 AND $15.00 PER SHARE - SEC FILING\n* ARCUS BIOSCIENCES INC SAYS INTENDS TO USE ABOUT $55.0 MILLION OF IPO PROCEEDS TO FUND CLINICAL DEVELOPMENT OF AB928 AND AB122 Source text: ( bit.ly/2oQRjdU )\n ", "external_links": ["http://thomsonreuters.com/en/about-us/trust-principles.html", "http://bit.ly/2oQRjdU"], "published": "2018-03-05T19:46:00.000+02:00", "crawled": "2018-03-06T22:26:13.011+02:00", "highlightTitle": ""}